Detection of infectious SARS-CoV-2 in ocular samples is linked to viral load in the nasopharynx

Front Cell Infect Microbiol. 2024 Mar 4:14:1332157. doi: 10.3389/fcimb.2024.1332157. eCollection 2024.

Abstract

Introduction: SARS-CoV-2 is known to infect respiratory tissue cells. However, less is known about infection of ocular tissue and potential infectivity of lacrimal fluid. With this study, we want to compare viral loads in eye and nasopharyngeal swabs and analyze these for infectious virus.

Methods: Between May 2020 and April 2021 ocular and nasopharyngeal swabs were collected from 28 SARS-CoV-2 infected patients treated on the corona virus disease 2019 (COVID-19)-ward of the University Hospital of Innsbruck, Austria. Samples with PCR detectable SARS-CoV-2 were analyzed via whole genome sequencing and an attempt was made to isolate infectious virus.

Results: At the time point of sample collection, 22 individuals were still PCR positive in nasopharyngeal samples and in 6 of these patients one or both ocular samples were additionally positive. CT-values in eyes were generally higher compared to corresponding nasopharyngeal samples and we observed a tendency for lower CT-values, i.e. increased viral load, in nasopharyngeal swabs of individuals with at least one infected eye, compared to those where ocular samples were PCR negative. Ocular and nasopharyngeal sequences from the same patient were assigned to the same variant, either the D614G or the Alpha variant. Infectious virus was successfully isolated from 9 nasopharyngeal swabs, however only from one of the seven PCR positive ocular samples.

Conclusion: We could detect SARS-CoV-2 in eyes of some of the infected patients albeit at lower levels compared to nasopharyngeal swabs. However, our results also indicate that lacrimal fluid might be infectious in patients with high viral load.

Keywords: COVID-19; Oxford Nanopore Technology; SARS-CoV-2; nasopharyngeal swab; ocular swab; ocular transmission; virus culture; whole genome sequencing.

MeSH terms

  • COVID-19* / diagnosis
  • Humans
  • Nasopharynx
  • RNA, Viral / analysis
  • RNA, Viral / genetics
  • SARS-CoV-2* / genetics
  • Specimen Handling / methods
  • Viral Load

Substances

  • RNA, Viral

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.